Sleep disturbances (eg, difficulty to initiate or maintain sleep) and poor sleep quality are
major health concerns that accompany several neurological and neuropsychiatric clinical …

Background Repetitive transcranial magnetic stimulation (rTMS) is an increasingly used
treatment for patients with depression. The use of rTMS in depression is supported by over …

Anxiety is currently one of the main mood changes and can impair the quality of life of the
individual when associated with other neurological or psychiatric disorders …

Abstract Objective Cognitive performance in Major Depressive Disorder (MDD) is frequently
impaired and related to functional outcomes. Repetitive Transcranial Magnetic Stimulation …

Background Patients with insomnia are often accompanied by cognitive dysfunction, which
seriously affects the quality of life of patients. Repetitive transcranial magnetic stimulation …

Study objectives Sleep disruption is a significant symptom of major depressive disorder
(MDD). To our knowledge, no prior work has examined the impact of repetitive transcranial …

There is growing enthusiasm into the frontal-vagal network theory of major depressive
disorder (MDD) and the potential role of a frontal-vagal network in the therapeutic …

Aim Cognitive deficits are recognized features of depressive disorders in youth aged 12–25.
These deficits are distressing, predict functional impairment and limit the effectiveness of …

Background Late-life depression (LLD) is associated with cognitive impairment, yet
substantial heterogeneity exists among patients. Data on the extent of cognitive impairments …

Objective Psychomotor retardation is a core clinical component of Major Depressive
Disorder responsible for disability and is known as a treatment response marker of …